Full Text View
Tabular View
No Study Results Posted
Related Studies
Incentive Programs for Female Substance Abusers Who Smoke - 3
This study is ongoing, but not recruiting participants.
Study NCT00064922   Information provided by National Institute on Drug Abuse (NIDA)
First Received: July 15, 2003   Last Updated: May 23, 2008   History of Changes

July 15, 2003
May 23, 2008
January 2002
 
 
 
Complete list of historical versions of study NCT00064922 on ClinicalTrials.gov Archive Site
 
 
 
Incentive Programs for Female Substance Abusers Who Smoke - 3
Incentive Programs for Female Substance Abusers Who Smoke

The purpose of this study is to examine the effects of incentive programs for the treatment of nicotine dependence in women who have problems with substance dependence.

This study will determine the influence of voucher-based CM on reducing smoking (and other drug) use during pregnancy or in post-partum women with children under 1 year of age living with them, or in non-pregnant females who smoke. We are targeting smoking cessation since cigarette use is so prevalent in our service. We will compare a control group to two different voucher-based contingent-reinforcement procedures: one that targets smoking abstinence alone vs. one that offers additional incentives for negative BAL and urinalysis results.

Phase II, Phase III
Interventional
Treatment, Active Control
Tobacco Use Disorder
Behavioral: Behavior Therapy
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
90
May 2005
 

Inclusion Criteria:

  • Pregnant and or post-partum with at least one child under 1 year old living with them, or non-pregnant, non-post-partum females or previous participant in this study protocol
  • Nicotine Dependent as confirmed by DSM-IV checklist
  • Current cigarette smoker
  • Breath CO reading of at least 8 ppm at the time of the initial study screening
  • Current client with the Shields for Families (Shields) treatment programs

Exclusion Criteria:

  • Non-smoker
Female
15 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00064922
 
NIDA-13638-3, R01-13638-3
National Institute on Drug Abuse (NIDA)
 
Principal Investigator: Leslie Amass, Ph.D. Los Angeles Treatment Research Center
National Institute on Drug Abuse (NIDA)
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP